Fresenius Medical Care AG KGaA Net Profit Margin 2010-2022 | FMS
Current and historical net profit margin for Fresenius Medical Care AG KGaA (FMS) from 2010 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue. Fresenius Medical Care AG KGaA net profit margin for the three months ending March 31, 2022 was .
| Fresenius Medical Care AG KGaA Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2022-03-31 |
$20.87B |
$1.02B |
4.90% |
| 2021-12-31 |
$20.84B |
$1.15B |
5.50% |
| 2021-09-30 |
$20.79B |
$1.10B |
5.31% |
| 2021-06-30 |
$20.71B |
$1.19B |
5.76% |
| 2021-03-31 |
$20.53B |
$1.32B |
6.42% |
| 2020-12-31 |
$20.40B |
$1.33B |
6.51% |
| 2020-09-30 |
$20.21B |
$1.49B |
7.38% |
| 2020-06-30 |
$19.97B |
$1.45B |
7.26% |
| 2020-03-31 |
$19.83B |
$1.35B |
6.80% |
| 2019-12-31 |
$19.57B |
$1.34B |
6.87% |
| 2019-09-30 |
$19.40B |
$1.45B |
7.45% |
| 2019-06-30 |
$19.21B |
$1.41B |
7.32% |
| 2019-03-31 |
$19.35B |
$2.31B |
11.92% |
| 2018-12-31 |
$19.54B |
$2.34B |
11.97% |
| 2018-09-30 |
$19.87B |
$2.32B |
11.66% |
| 2018-06-30 |
$20.25B |
$2.35B |
11.60% |
| 2018-03-31 |
$20.14B |
$1.46B |
7.25% |
| 2017-12-31 |
$20.10B |
$1.45B |
7.19% |
| 2017-09-30 |
$19.55B |
$1.38B |
7.03% |
| 2017-06-30 |
$19.05B |
$1.35B |
7.06% |
| 2017-03-31 |
$18.55B |
$1.34B |
7.24% |
| 2016-12-31 |
$17.91B |
$1.24B |
6.94% |
| 2016-09-30 |
$17.57B |
$1.17B |
6.67% |
| 2016-06-30 |
$17.20B |
$1.10B |
6.40% |
| 2016-03-31 |
$16.98B |
$1.05B |
6.17% |
| 2015-12-31 |
$16.74B |
$1.03B |
6.15% |
| 2015-09-30 |
$16.71B |
$1.05B |
6.27% |
| 2015-06-30 |
$16.59B |
$1.06B |
6.37% |
| 2015-03-31 |
$16.23B |
$1.05B |
6.47% |
| 2014-12-31 |
$15.83B |
$1.05B |
6.60% |
| 2014-09-30 |
$15.38B |
$1.06B |
6.89% |
| 2014-06-30 |
$14.93B |
$1.06B |
7.11% |
| 2014-03-31 |
$14.71B |
$1.09B |
7.41% |
| 2013-12-31 |
$14.61B |
$1.11B |
7.60% |
| 2013-09-30 |
$14.45B |
$1.02B |
7.05% |
| 2013-06-30 |
$14.20B |
$1.02B |
7.15% |
| 2013-03-31 |
$14.02B |
$1.04B |
7.43% |
| 2012-12-31 |
$13.80B |
$1.19B |
8.59% |
| 2012-09-30 |
$13.42B |
$1.24B |
9.23% |
| 2012-06-30 |
$13.24B |
$1.25B |
9.42% |
| 2012-03-31 |
$13.01B |
$1.22B |
9.38% |
| 2011-12-31 |
$12.80B |
$1.07B |
8.37% |
| 2011-09-30 |
$12.64B |
$1.03B |
8.17% |
| 2011-06-30 |
$12.46B |
$1.00B |
8.04% |
| 2011-03-31 |
$12.21B |
$0.99B |
8.09% |
| 2010-12-31 |
$12.05B |
$0.98B |
8.11% |
| 2010-09-30 |
$11.92B |
$0.95B |
8.00% |
| 2010-06-30 |
$11.75B |
$0.93B |
7.92% |
| 2010-03-31 |
$11.57B |
$0.90B |
7.81% |
| 2009-12-31 |
$11.25B |
$0.89B |
7.92% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$14.716B |
$20.846B |
|
Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products..
|
